Results for tag: "HER2 Positive Breast Cancer Drug"

The HER2 Positive Breast Cancer Drug market is a subset of the larger Breast Cancer Drug market. HER2 Positive Breast Cancer Drugs are used to treat breast cancer that is positive for the HER2 gene. These drugs work by targeting the HER2 gene, which is overexpressed in some breast cancer cells. HER2 Positive Breast Cancer Drugs are typically used in combination with other treatments, such as chemotherapy and radiation. The HER2 Positive Breast Cancer Drug market is highly competitive, with many companies offering different treatments. Some of the major players in the market include Roche, Novartis, Pfizer, AstraZeneca, and Eli Lilly. These companies offer a variety of treatments, including monoclonal antibodies, small molecule inhibitors, and targeted therapies. Show Less Read more